Back to Search Start Over

Nicotinic receptor modulation of the default mode network.

Authors :
Hahn B
Harvey AN
Concheiro-Guisan M
Huestis MA
Ross TJ
Stein EA
Source :
Psychopharmacology [Psychopharmacology (Berl)] 2021 Feb; Vol. 238 (2), pp. 589-597. Date of Electronic Publication: 2020 Nov 20.
Publication Year :
2021

Abstract

Rationale: Previous neuroimaging studies of cognition involving nicotinic acetylcholine receptor (nAChR) agonist administration have repeatedly found enhanced task-induced deactivation of regions of the default mode network (DMN), a group of brain systems that is more active at rest and mediates task-independent thought processes. This effect may be related to pro-cognitive nAChR agonist effects OBJECTIVES: The present study sought to test whether nAChR modulation of the DMN is bi-directional, i.e., whether a nAChR antagonist would reduce task-induced deactivation.<br />Methods: Eighteen healthy non-smokers underwent functional magnetic resonance imaging while performing a letter N-back task. Scans were performed after nicotine administration (7 mg/24 h, transdermally), after administration of the nAChR antagonist mecamylamine (7.5 mg, p.o.), and after double placebo, in counterbalanced sequence. Blood-oxygen-level-dependent (BOLD) signal was analyzed within ventromedial prefrontal cortex (vmPFC) and posterior cingulate cortex (PCC) regions of interest-central hubs of the DMN in which consistent nAChR agonist-induced changes had previously been identified.<br />Results: Nicotine enhanced hit rate in both the 0-back and 2-back condition, while mecamylamine slowed reaction time in the 2-back condition. Mecamylamine reduced task-induced deactivation of vmPFC and PCC. Nicotine had no significant effects on the BOLD signal.<br />Conclusions: The finding that nAChR tone reduction by mecamylamine weakened task-induced DMN deactivation indicates that a constant tone of nAChR activation helps regulate DMN activity in healthy individuals. This suggests that low nAChR tone may play a causal role in DMN dysregulation seen in conditions such as mild cognitive impairment or Alzheimer's disease.

Details

Language :
English
ISSN :
1432-2072
Volume :
238
Issue :
2
Database :
MEDLINE
Journal :
Psychopharmacology
Publication Type :
Academic Journal
Accession number :
33216167
Full Text :
https://doi.org/10.1007/s00213-020-05711-9